During EFY 2011, EPSA has measured the forecast accuracy rate for malaria, TB, HIV/AIDS, family planning supplies and the average forecast accuracy rate for health program pharmaceuticals was found to be 82.78%. Moreover, for selected Revolving Drug Fund (RDF) pharmaceuticals, the forecast accuracy rate has reached to 62.3%.
Process Indicator:
Annual quantification and forecasting conducted
Organisation:
Fiscal Year:
Quarter: